Clinical trial
A Study to Investigate the Cardiovascular Safety of Apricitabine in Healthy…
NCT00334659 · Avexa, Industry · Completed
Key facts
| NCT number | NCT00334659 |
|---|---|
| Title | A Study to Investigate the Cardiovascular Safety of Apricitabine in Healthy Subjects |
| Official title | A Double-blind, Placebo-controlled, Positive Controlled, Randomized, Crossover Study to Investigate the Cardiovascular Safety of Apricitabine in Healthy Subjects |
| Lead sponsor | Avexa, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | apricitabine |
| Enrollment | 37 |
| Start date | Jun 1, 2006 |
| Primary completion | Aug 1, 2006 |
| Completion | Aug 1, 2006 |
| First posted | Jun 8, 2006 |
| Last update posted | Jun 23, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: